LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients.

Uyar, Mehtap Erkmen / Yucel, Piril / Ilin, Sena / Bal, Zeynep / Yildirim, Saliha / Uyar, Ahmet Senol / Akay, Tankut / Tutal, Emre / Sezer, Siren

Cardiovascular journal of Africa

2016  Volume 27, Issue 3, Page(s) 128–133

Abstract: Background: Iloprost, a stable prostacyclin analog, is used as a rescue therapy for severe peripheral arterial disease (PAD). It has systemic vasodilatory and anti-aggregant effects, with severe vasodilatation potentially causing organ ischaemia when ... ...

Abstract Background: Iloprost, a stable prostacyclin analog, is used as a rescue therapy for severe peripheral arterial disease (PAD). It has systemic vasodilatory and anti-aggregant effects, with severe vasodilatation potentially causing organ ischaemia when severe atherosclerosis is the underlying cause. In this study, we retrospectively analysed renal outcomes after iloprost infusion therapy in 86 patients.
Methods: Eighty-six patients with PAD who received iloprost infusion therapy were retrospectively analysed. Clinical and biochemical parameters were recorded before (initial, Cr1), during (third day, Cr2), and after (14th day following the termination of infusion therapy, Cr3) treatment. Acute kidney injury (AKI) was defined according to KDIGO guidelines as a ≥ 0.3 mg/dl (26.52 µmol/l) increase in creatinine levels from baseline within 48 hours.
Results: Cr2 (1.46 ± 0.1 mg/dl) (129.06 ± 8.84 µmol/l) and Cr3 (1.53 ± 0.12 mg/dl) (135.25 ± 10.61 µmol/l) creatinine levels were significantly higher compared to the initial value (1.15 ± 0.6 mg/dl) (101.66 ± 53.04 µmol/l). AKI was observed in 36 patients (41.86%) on the third day of iloprost infusion. Logistic regression analysis revealed smoking and not using acetylsalicylic acid as primary predictors (p = 0.02 and p = 0.008, respectively) of AKI during iloprost treatment. On the third infusion day, patients' urinary output significantly increased (1813.30 ± 1123.46 vs 1545.17 ± 873.00 cm
Conclusion: While iloprost treatment is effective in patients with PAD who are not suitable for surgery, severe systemic vasodilatation can cause renal ischaemia, resulting in nonoliguric AKI. Smoking, no acetylsalicylic acid use, and lower diastolic blood pressure are the clinical risk factors for AKI during iloprost treatment.
MeSH term(s) Acute Kidney Injury/blood ; Acute Kidney Injury/chemically induced ; Acute Kidney Injury/diagnosis ; Acute Kidney Injury/mortality ; Aged ; Aged, 80 and over ; Arterial Pressure ; Aspirin/therapeutic use ; Atherosclerosis/diagnostic imaging ; Atherosclerosis/drug therapy ; Atherosclerosis/mortality ; Atherosclerosis/physiopathology ; Biomarkers/blood ; Chi-Square Distribution ; Creatinine/blood ; Female ; Humans ; Iloprost/administration & dosage ; Iloprost/adverse effects ; Infusions, Intravenous ; Kaplan-Meier Estimate ; Logistic Models ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/adverse effects ; Protective Factors ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Severity of Illness Index ; Smoking/adverse effects ; Time Factors ; Treatment Outcome ; Up-Regulation ; Vasodilator Agents/administration & dosage ; Vasodilator Agents/adverse effects
Chemical Substances Biomarkers ; Platelet Aggregation Inhibitors ; Vasodilator Agents ; Creatinine (AYI8EX34EU) ; Iloprost (JED5K35YGL) ; Aspirin (R16CO5Y76E)
Language English
Publishing date 2016-05
Publishing country South Africa
Document type Journal Article
ZDB-ID 2383233-2
ISSN 1680-0745 ; 1996-3467 ; 1015-9657 ; 1995-1892
ISSN (online) 1680-0745 ; 1996-3467
ISSN 1015-9657 ; 1995-1892
DOI 10.5830/CVJA-2015-051
Shelf mark
Zs.A 4813: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top